Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 06-2006 | 12-2005 | 06-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,130 | N/A | -14,010 | N/A | -16,470 |
| Depreciation Amortization | 240 | N/A | 240 | N/A | 310 |
| Other Working Capital | 330 | N/A | -1,260 | N/A | 1,610 |
| Other Operating Activity | 1,980 | 0 | 4,570 | 0 | 60 |
| Operating Cash Flow | $-12,580 | $N/A | $-10,460 | $N/A | $-14,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 80 | N/A | -10 | N/A | -170 |
| Other Investing Activity | -20,910 | 0 | 9,530 | 0 | 7,820 |
| Investing Cash Flow | $-20,830 | $N/A | $9,520 | $N/A | $7,650 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 24,460 | 0 | 1,510 | 0 | 15,440 |
| Financing Cash Flow | $24,460 | $N/A | $1,510 | $N/A | $15,440 |
| Beginning Cash Position | 13,360 | N/A | 12,780 | N/A | 4,180 |
| End Cash Position | 4,400 | N/A | 13,360 | N/A | 12,780 |
| Net Cash Flow | $-8,960 | $N/A | $570 | $N/A | $8,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,580 | N/A | -10,460 | N/A | -14,490 |
| Free Cash Flow | -12,580 | 0 | -10,460 | 0 | -14,490 |